Anil Pareek

ORCID: 0000-0002-1850-849X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Systemic Lupus Erythematosus Research
  • Drug-Induced Ocular Toxicity
  • Sodium Intake and Health
  • Hormonal Regulation and Hypertension
  • Inflammatory mediators and NSAID effects
  • Lipoproteins and Cardiovascular Health
  • Pain Mechanisms and Treatments
  • Analytical Methods in Pharmaceuticals
  • Pharmaceutical Practices and Patient Outcomes
  • Rheumatoid Arthritis Research and Therapies
  • Heart Rate Variability and Autonomic Control
  • Eicosanoids and Hypertension Pharmacology
  • Lipid metabolism and disorders
  • Natural Antidiabetic Agents Studies
  • Computational Drug Discovery Methods
  • Adipokines, Inflammation, and Metabolic Diseases
  • Diabetes Treatment and Management
  • Malaria Research and Control
  • Hemodynamic Monitoring and Therapy
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Estrogen and related hormone effects
  • COVID-19 Clinical Research Studies
  • Retinal Diseases and Treatments
  • Peripheral Neuropathies and Disorders

Ipca Laboratories (India)
2013-2024

GTx (United States)
2020

Weatherford College
2009-2020

Albert Einstein College of Medicine
2012

Mount Sinai Beth Israel
2012

Background: Several methods have been investigated recently to improve the solubility and bioavailability. Inclusion complex approach is a potential way for enhancing solubility. Aim of study: It could be said drug atorvastatin which has poor aqueous by making inclusion with water soluble compound Sulfobutylether-β-Cyclodextrin its Methods: complexes Sulfobutylether-β Cyclodextrin were formulated using kneading method one ratio one, two, three, four five. The studies phase tests unveil that...

10.37285/ijpsn.2025.18.1.9 article EN International Journal of Pharmaceutical Sciences and Nanotechnology 2025-02-15

Objective:To evaluate the efficacy and safety of atorvastatin + hydroxychloroquine fixed-dose combination tablets in comparison with alone treatment dyslipidemia.Methods:This double-blind, randomized, out-patient study was conducted 328 patients primary dyslipidemia having low-density lipoprotein cholesterol (LDL-C) ≥130 mg/dL (3.37 mmol/L) to ≤250 (6.48 triglycerides ≤400 (4.52 mmol/L). Eligible were randomized receive either 10 mg (n = 167) or 200 161) for 24 weeks.Clinical trial...

10.1185/03007995.2015.1087989 article EN Current Medical Research and Opinion 2015-10-08

Polymorphic light eruption is the most common photodermatosis characterized by nonscarring, pruritic, erythematous papules and plaques.To evaluate efficacy safety of hydroxychloroquine in comparison with chloroquine patients suffering from polymorphic eruption.This was a randomized, double-blind, comparative, multicentric study conducted at two centers. This enrolled 68 (58.1%) males, 49 (41.8%) females whose ages ranged 18-73 years average weight 57.89 +/- 8.27 kg. A total 117 were study....

10.4103/0378-6323.38401 article EN Indian Journal of Dermatology Venereology and Leprology 2008-01-01

Objective: Hydroxychloroquine (HCQ) has been used for a long time worldwide as therapy rheumatoid arthritis (RA). This trial was designed to determine whether HCQ efficacious and safe in Indian patients with RA.Research design methods: The multicentre, placebo controlled, randomized double-blind study. One hundred twenty-two RA were enrolled 3 different centres the (26 males 96 females age group of 18–60 years). Patients receive either hydroxychloroquine tablets (n = 61) two 200 mg daily or...

10.1185/030079907x219634 article EN Current Medical Research and Opinion 2007-08-09

Objective: The relationship of blood pressure (BP) to cardiovascular risk is linear, positive, and continuous. Lowering elevated BP reduces the events. primary objective this randomized, multicenter, comparative, 3-month, open-label study was evaluate antihypertensive efficacy losartan/chlorthalidone versus losartan/hydrochlorothiazide in mild-to-moderate essential hypertension. Methods: A total 137 eligible patients underwent a 2-week placebo washout period, following which 131 were...

10.1517/14656560902991514 article EN Expert Opinion on Pharmacotherapy 2009-06-11

To evaluate the efficacy and safety of etodolac-paracetamol combination in comparison with etodolac alone patients knee osteoarthritis (OA) flare-up.In this double-blind, double-dummy, randomized, comparative, multicentric, parallel group study, 220 either sex age range 40 to 70 years an OA flare-up were randomized (300 mg)-paracetamol (500 mg) or twice a day for 10 days. Efficacy outcomes average daily pain intensity score on 11-point visual analog scale, Western Ontario McMaster (WOMAC),...

10.1097/ajp.0b013e3181e15bba article EN Clinical Journal of Pain 2010-07-15

<b>Objective:</b> To evaluate the antihyperglycemic activity of atorvastatin and hydroxychloroquine combination in alloxan-induced diabetic rats.<br><b> Materials Methods:</b> Alloxan induced Wistar male rats were randomized into six groups 6 each. (Normal rats, control, (ATV), (HCQ), ATV 5 mg /kg + HCQ 100 mg/kg, 10 mg/kg 200 mg/kg). The treated for 9 days blood samples collected at baseline end therapy. These analyzed plasma glucose by autoanalyzer. Changes body weight, water, food intakes...

10.4103/0253-7613.55213 article EN Indian Journal of Pharmacology 2009-01-01

Thiazolidinediones (TZDs) are insulin sensitizers used for treatment of diabetes. We have previously reported that TZDs reduce estrogen synthesis by inhibiting aromatase activity in human granulosa cells (HGC). Multiple clinical trials demonstrated increase the risk fractures postmenopausal women with type 2 studied mouse osteoblasts alone or a co-culture HGC to determine whether TZD inhibition plays role their effects on bone metabolism. Mouse were cultured and without HGC, incubated medium...

10.1055/s-0032-1321874 article EN Hormone and Metabolic Research 2012-08-09

Objective: To compare the efficacy and safety of low-dose chlorthalidone + atenolol combination with amlodipine in stage I hypertensive patients uncontrolled on active run-in monotherapy.Methods: Newly diagnosed were randomized to monotherapy either 25 mg (98/300) or 6.25 (100/300) 2.5 (102/300). A total 282/300 (atenolol 92, 91, 99) completed phase successfully. Patients 33, 45, 47) received study treatment, namely 50 alone, mg, respectively. Efficacy therapy was evaluated by BP measurement...

10.1185/03007990802118071 article EN Current Medical Research and Opinion 2008-04-09

Objective: To demonstrate the clinical noninferiority of analgesic effect zaltoprofen (80 mg t.i.d.) compared with diclofenac (50 in active knee osteoarthritis patients. Method: In this multicentric, double-blind, double-dummy, randomized, parallel-group, comparative study, 213 patients either sex, aged 40 – 65 years having radiological and clinically confirmed primary were randomized to (n = 105) or 108) followed-up at weeks 1, 2, 3 4. The treatment period was preceded by a washout 1 week....

10.1517/14656566.2011.566867 article EN Expert Opinion on Pharmacotherapy 2011-04-07

Abstract Objective To establish efficacy and safety of artesunate/lumefantrine fixed‐dose combination ( FDC ) in comparison with artemether/lumefantrine treatment uncomplicated P lasmodium falciparum malaria. Methods Confirmed cases . malaria were randomly assigned to receive artesunate (100 mg)/lumefantrine (480 mg) ASLF or artemether (80 AMLF tablets for 3 days. Patients followed up on Day 7, 14, 21 28. Results Of the 158 enrolled patients, 144 completed study. Seventy‐three patients...

10.1111/tmi.12088 article EN Tropical Medicine & International Health 2013-03-14

Abstract Hydroxychloroquine, an antimalarial agent has also been found to possess antidiabetic action. Onset of type-2 diabetes (T2DM) and cardiovascular disease is now considered be the outcome systemic inflammation. Many clinical trials are targeting inflammation reduce risk. Anti-inflammatory drugs with effects may valuable therapeutic intervention massive risk in T2DM. In this review, action potential cardioprotective role hydroxychloroquine discussed. By virtue its antidiabetic, lipid...

10.1515/rjdnmd-2017-0043 article EN Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2017-12-01

We have read the study design “Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor on 24-h central blood pressure vascular hemodynamic parameters hypertensive patients: for a multicenter, double-blinded, active controlled, phase 4, randomized trial” by Oh GC, et al. interest. The authors aim to compare efficacy amlodipine or hydrochlorothiazide (HCTZ) an ARB. However, we wish highlight that chlorthalidone (CTD) is evidence-based...

10.1186/s40885-018-0089-1 article EN cc-by Clinical Hypertension 2018-02-23

Objective: Many T2D patients have inadequate glycemic control despite conventional therapy of dual OHAs. Treating such in developing countries is a challenge as newer drugs are comparatively costly or may apprehensions for injectable insulin. Objective this observational study was to evaluate effectiveness add-on HCQ these patients. Methods: A prospective, observational, multi-centre conducted where 1,007 (age between 18-65 years), uncontrolled on combination two OHAs, with HbA1c ≥7.5%,...

10.2337/db19-1189-p article EN Diabetes 2019-06-01

Osteoarthritis (OA) is the most common form of arthritis, affecting millions people worldwide.It an inflammatory, degenerative and progressive disease which worsens over time, resulting in joint pain, swelling stiffness.As progresses, pain stiffness become severe making daily tasks difficult, thereby quality life.The treatment osteoarthritis mainly focuses on management inflammation to control symptoms as complete reversal not practical.Non-steroidal anti-inflammatory drugs (NSAIDs) are...

10.31080/asor.2020.03.0232 article EN Acta Scientific Orthopaedics 2020-11-30

Hydroxychloroquine, due to its multifaceted pleiotropic benefits including anti-inflammatory effects has great potential in reducing cardiovascular (CV) morbidity and mortality. CV outcome data of hydroxychloroquine is available through 2 retrospective studies rheumatoid arthritis patients, both which have not considered congestive heart failure (CHF) as an measure. CHF important more common than myocardial infarction stroke; increased age associated with risk CHF. Hydroxychloroquine...

10.1093/ecam/pvw046 article EN European Heart Journal - Cardiovascular Pharmacotherapy 2016-12-20

Prostate carcinoma is a highly prevalent biologically and clinically heterogeneous disease. Unfortunately, within 5 years of diagnosis, 10-20% patients acquire castration-resistant prostate cancer (CRPC) in spite multiple surgical non-surgical therapy choices. The clinical context CRPC heterogeneous, encompassing with asymptomatic prostate-specific antigen (PSA) elevation following ADT failure good performance status, as well those experiencing severe, incapacitating symptoms rapidly...

10.18203/2320-6012.ijrms20240559 article EN International Journal of Research in Medical Sciences 2024-02-28
Coming Soon ...